1 Aug
2006

Pfizer wins latest round in Chinese Viagra dispute

When the patent relating to Viagra
was invalidated in China, it created
headlines across the world. But as
the latest decision in the case
shows, the dispute is actually an
example of the country’s IP system
functioning properly